Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Cash flows from operating activities:
Net income	$ 758	$ 576
Adjustments to reconcile net income to net cash provided by operations:
Gain on sale of business	(90)	0
Asset impairment charges	0	96
Depreciation and amortization	66	59
Stock-based compensation expense	18	13
Deferred income tax provision (benefit)	3	(6)
Change in fair value of contingent consideration	1	0
Other, net	(2)	17
Changes in assets and liabilities:
Accounts receivable	(21)	(106)
Inventories	(320)	(288)
Other current assets	28	(19)
Accounts payable and accrued expenses	(69)	66
Accrued income taxes	(2)	(36)
Other operating assets and liabilities	(8)	38
Cash provided by operating activities	362	410
Cash flows from investing activities:
Proceeds from sale of business	194	0
Business acquisitions, net of cash acquired	0	(1,195)
Additions to property, plant, and equipment	(148)	(116)
Proceeds from sale of property, plant, and equipment	13	12
Other, net	4	(1)
Cash provided by (used for) investing activities	63	(1,300)
Cash flows from financing activities:
Proceeds from short-term borrowings, maturities greater than 90 days	0	600
Net change in short-term borrowings	492	402
Repayment of long-term debt	0	(250)
Payments of withholding taxes related to stock-based awards	(4)	(5)
Acquisition of treasury stock	(400)	0
Dividends paid	(300)	(279)
Cash provided by (used for) financing activities	(212)	468
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	2	(15)
Net increase (decrease) in cash, cash equivalents, and restricted cash	215	(437)
Cash, cash equivalents, and restricted cash at beginning of period	384	874
Cash, cash equivalents, and restricted cash at end of period	599	437
Less: Restricted cash (included in other current assets) at end of period	(10)	(9)
Cash and cash equivalents at end of period	$ 589	$ 428